Clinical trial
Biologic Characterization of Patients With Immune Thrombocytopenia (ITP)
NCT05694325 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biologic Characterization of Patients With Immune Thrombocytopenia (ITP)
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 27, 2023
- Completion date
- November 30, 2026
- Enrollment
- 200 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
immune thrombocytopenia